Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
[ad_1] Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. Danish drugmaker Novo Nordisk
Adding new India-specific dimensions to obesity diagnosis
[ad_1] For decades, body mass index (BMI) has been the primary tool for diagnosing obesity worldwide. BMI is calculated by dividing a person’s weight (in
Novo Nordisk foundation’s obesity head works as paid adviser to chocolate maker Ferrero
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of the
Roche signs biggest-ever obesity drug deal
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche has signed the
